Navigation Links
CMPMedica Expands SearchMedica.com with Multiple Additional Vertical Search Applications co-developed with Convera(R)
Date:3/24/2008

ue goals and build loyal online professional communities.

This release, including any statements from Convera personnel, contains statements about Convera's future expectations, performance, plans, and prospects, as well as assumptions about future events. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, business and economic conditions and trends; the ability to continue funding operating losses; fluctuations in operating results including impacts from reduced corporate IT spending and lengthier sales cycles; continued success in technological advances and development; possible disruption in commercial activities caused by terrorist activity and armed conflict, such as changes in logistics and security arrangements; reduced customer demand relative to expectations; competitive factors; and other risk factors listed from time to time in the company's reports to the Securities and Exchange Commission. Actual results may differ materially from our expectations as the result of these and other important factors relating to Convera's business and product development efforts, which are further described in Convera's filings with the SEC. These filings can be obtained from the SEC's website located at http://www.sec.gov. Any forward-looking statements are based on information available to Convera on the date of this release, and Convera assumes no obligation to update such statements. Convera(R) and the Convera design logo are trademarks of Convera in the United States and other countries.


'/>"/>
SOURCE Convera
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nova Biosource Fuels Expands Senior Executive Team
2. Finesse Solutions Expands by Opening Sales and Service Centers
3. Evotec Expands Collaboration With InterMune
4. Novo Nordisk Expands U.S. Headquarters in New Jersey
5. Tunnell Consulting Expands Biotechnology Expertise
6. Progen Expands Board of Directors
7. BioVascular, Inc. Expands Executive Team
8. United BioSource Expands Regulatory Affairs Capabilities
9. Valensa Expands Astaxanthin Extraction Capacity
10. Progen Expands Drug Development Pipeline Through Acquisition of CellGate
11. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...VLP vaccine trial enrollment positions Company to ... this year, ROCKVILLE, Md., Sept. 19 Novavax, In...ed enrollment of healthy,volunteers in a Phase IIa...ased seasonal influenza vaccine. The Phase IIa ran...uating the safety and immunogenicity of,different ...
...mber 19 Thirty seven medical,experts in psychiatr...,community to take urgent action to optimize servi...llness such as schizophrenia or bipolar,disorder(i...l author of Comorbid,Somatic Illnesses in Patients...d Research Challenges which was published in the J...
...os, Inc. (Amex: NEP ),today announced that the Co...erican Stock Exchange (AMEX) indicating that the C...s of the continued listing standards of,Section 10...oted the,Company,s failure to comply with Section ... stockholders, equity of less than $6,000,000 and ...
Other Biology Technology:Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 2Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 3Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 4Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3Nephros Receives Non-Compliance Notification from AMEX 2Nephros Receives Non-Compliance Notification from AMEX 3
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2SETO Holdings Inc Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia 52734 1SETO Holdings Inc Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia 52734 2OrthoDynamix LLC Launches ArthroSteer 28TM 29 3A Reaching New Limits in Arthroscopy 52732 1OrthoDynamix LLC Launches ArthroSteer 28TM 29 3A Reaching New Limits in Arthroscopy 52732 2Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 1Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 2Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 3
... has received a six-year contract from the U.S. Na...for the AN/UYQ-70 (Q-70) Advanced Display System. ...pport at over $13 million a year for the first two...he next four years, bringing the total potential c...ollows a recently awarded $525.6 million modificat...
...s and bumble bees are predictable in the way they ... one flower to an adjacent cluster of flowers in t... a direct affect on their ability to hunt for poll...d production that results when pollen moves from o...perienced more attention in part due to the recent...
...suffering from a blood disorder that prevents prop...at may dramatically improve their health. There ar...iduals in the U.S. diagnosed with chronic immune t...se that dramatically reduces the number of platele...nd, rarely, life-threatening brain hemorrhages. ,...
Other Biology News:U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support 2Flight of the bumble (and honey) bee 2Lancet study supports new, highly effective treatment for blood disorder 2Lancet study supports new, highly effective treatment for blood disorder 3
Bio-Stack Microplate Stacker from BioTek Instruments
...l applications for the use of small interfering RN... the RNA interference,(RNAi) pathway have generate...r biology fields. siRNA for experimental use can b...atically, and then transfected into the target cel...
...om Array Service enables scientists who have acces...entation to have FAST Slides printed with proteins.... Processing of the arrays is performed by the cus...s your needs with an expert and define the best ad...
...eets the demands of the routine trace metal analyt...le, robust and simple to use instrumentation. The ...t challenging sample matrices found in the environ...est analytical challenges found in the clinical, f...
Biology Products: